About the Company
We do not have any company description for Omega Therapeutics, Inc. at the moment.
Exchange
OTC
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Omega Therapeutics, Inc.
Omega Therapeutics, Inc. (OMGA) Surges 19.6%: Is This an ... - Nasdaq
Omega Therapeutics, Inc. (OMGA) shares rallied 19.6% in the last trading session to close at $7.19. This move can be attributable to notable volume with a higher number of shares being traded than ...
Omega Therapeutics, Inc. (OMGA) Surges 37.2%: Is This an ... - Nasdaq
Omega Therapeutics, Inc. (OMGA) shares ended the last trading session 37.2% higher at $6.60. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...
Omega Therapeutics Reports Third Quarter 2023 Financial Results and ...
Net loss for the third quarter of 2023 was $22.2 million, compared to $25.8 million for the third quarter of 2022, driven predominantly by a decrease in R&D expenses. About Omega Therapeutics ...
Omega Therapeutics: 2023 Could Well Be A Turning Point
About Omega Therapeutics, Inc., and Its Technology Based in Cambridge, Massachusetts, Omega Therapeutics, Inc. is a clinical-stage biotechnology company that owns the OMEGA platform technology.
OMGAQ - Omega Therapeutics Inc Valuation | Morningstar
Review the current valuation for Omega Therapeutics Inc (OMGAQ:PINX) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation information.
Omega Therapeutics to Present New Preclinical Data on OTX-2101 at the ...
CAMBRIDGE, Mass., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of ...
Omega Therapeutics, Inc. (OMGA) Upgraded to Buy: What Does It Mean for ...
Omega Therapeutics, Inc. (OMGA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
OMEGA THERAPEUTICS INC COM - Benzinga
OMEGA THERAPEUTICS INC COM (NASDAQ:OMGA) Stock, Insider Trading Activity OMEGA THERAPEUTICS INC COM: Insider buying and selling updated today.
Omega Therapeutics, Inc. (OMGA) Surges 37.2%: Is This an Indication of ...
Omega Therapeutics, Inc. is part of the Zacks Medical - Biomedical and Genetics industry. Novavax (NVAX), another stock in the same industry, closed the last trading session 6.3% lower at $9.78.
OMGAQ - Omega Therapeutics Inc News | Morningstar
Read about Omega Therapeutics Inc (OMGAQ:PINX) stock and today's latest news and financial updates.
Similar Companies
Loading the latest forecasts...